During the past decade, CH Saint Malo conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 1 clinical trials were completed, i.e. on average, 1.9% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH Saint Malo" #1 sponsor was "Rennes University Hospital" with 13 trials, followed by "Federation Francophone de Cancerologie Digestive" with 8 trials sponsored, "University Hospital, Brest" with 7 trials sponsored, "The Lymphoma Academic Research Organisation" with 4 trials sponsored and "Centre Hospitalier Departemental Vendee" with 4 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH Saint Malo" #1 collaborator was "Ministry of Health, France" with 5 trials as a collaborator, "National Cancer Institute, France" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials as a collaborator and "Institut National de la Santé Et de la Recherche Médicale, France" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "CH Saint Malo" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Metastatic Colorectal Cancer" (3 trials), "Acute Respiratory Failure" (2 trials), "Critical Illness" (2 trials) and "Multiple Myeloma" (2 trials). Many other conditions were trialed in "CH Saint Malo" in a lesser frequency.

Most popular intervention types in "CH Saint Malo" are "Drug" (30 trials), "Other" (19 trials), "Procedure" (8 trials), "Device" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Irinotecan" (3 trials), "Oxaliplatin" (3 trials), "Folinic Acid" (2 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "CH Saint Malo" are 71 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "CH Saint Malo". undefined are not yet recruiting, 25 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in CH Saint Malo, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in CH Saint Malo, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 16 trials that are defined as “Not Applicable".